The pharmaceutical industry is providing us with a pathway out of this pandemic but manufacturing delays and other disruptions are proving challenging.

On this episode of Crisis to Resilience, you’ll hear from Pamela Fralick, the President of Innovative Medicines Canada about the drug policies and investments that can contribute to a healthier more resilient Canada.